Oct 5, 2009 | Laboratory News, Laboratory Pathology
Up to 400 times more sensitive than existing ELISA-based methods Detecting any of seven cancers in their earliest stages may be feasible through the use of a new biomarker chip that was recently unveiled by scientists from Stanford University’s Center for Magnetic Nanotechnology. To give their biomarker chip increased sensitivity over fluorescent detection methods, the scientists use magnetic technologies to accomplish detection. Reporting in Proceedings of the National Academy of Sciences...
